CLINICAL
RETHINKING THE RESEARCH
Dr Jordan Faulkner on why practitioners need to question the evidence behind the treatments they offer.
Critical appraisal is, in my opinion, one of the most undervalued skills in aesthetic medicine. We devote considerable attention to learning how to deliver treatments. We should be equally concerned with how we decide whether those treatments are worth delivering and whether the evidence supports what we tell our patients.
THE GAP IN OUR EDUCATION
For many of us, entering aesthetic medicine means becoming self-employed and taking responsibility for our own education. We choose our courses, conferences and mentors. That freedom is valuable, but it also means that the content and quality of our education depend on our own judgement.
Compare this with the route of a typical NHS surgical trainee. From medical school onwards, trainees encounter repeated competitive bottlenecks, particularly when applying for core surgical and higher specialty training, and later for consultant appointments. Academic achievements, including publications, presentations and higher research degrees, can strengthen an application.
Alongside journal clubs, supervision and academic discussion, they create opportunities to understand how studies are designed, where bias arises and why a conclusion may exceed the findings. A publication record does not guarantee sound critical judgement, but the training environment repeatedly encourages clinicians to engage with the literature.
A DIFFERENT EDUCATIONAL LANDSCAPE
Aesthetic medicine has no equivalent shared sequence of academic incentives. Clinicians enter from different professions and at different career stages.
Those moving into independent practice early may have had fewer opportunities to develop these skills.
This variation reflects different educational journeys, but it has consequences when we are all expected to assess increasingly sophisticated treatment claims.
Much of our continuing education is delivered or supported by manufacturers and distributors. However, its commercial interests influence which products are studied, which findings receive attention and how those findings are presented. A scientifically accurate slide can still convey a selective account of the evidence.
EVIDENCE AS A MARKETING CLAIM
The difficulty is often the distance between a finding and the claim built upon it. Increased collagen expression in a laboratory experiment may be presented as evidence of clinical rejuvenation. Improvement in an uncontrolled study may become a claim of superiority. A small study with short follow-up may be used to offer reassurance about safety that it was never designed to establish. Each step can sound plausible while extending beyond what has scientifically been demonstrated.
This is of utmost importance because treatment decisions carry clinical and financial consequences for patients. If we cannot interrogate the evidence ourselves, we risk adopting protocols because they are confidently taught, without understanding their limitations. Our own investment in a product, or our relationship with a company, can make that scrutiny more uncomfortable. It also makes it more necessary.
RESEARCH UNDER THE MICROSCOPE
From a practical perspective, critical appraisal becomes more manageable when approached systematically. The Critical Appraisal Skills Programme (CASP) provides checklists for different study designs, organised around validity, results and clinical relevance. The appropriate checklist should be used for the paper being read.
As a starting point, I would encourage clinicians to ask the following five questions, informed by those principles:
1. What question does this study answer? Identify the population, intervention, comparator and outcome.
2. Is the study design capable of supporting the conclusion? Consider the control group, randomisation, blinding, sample size and follow-up.
3. How large and credible is the benefit? Look beyond statistical significance. Examine effect sizes, confidence intervals and validated outcomes.
4. Where might bias have entered? Examine recruitment, missing data, selective reporting, funding and conflicts of interest.
5. Should these findings change my practice? Check whether the patients, product and protocol reflect your practice.
These questions are a starting point, and the skill develops through repeated use. We do not all need to become researchers. We do, however, need sufficient understanding to recognise the limits of the evidence on which we base our decisions. In a field where so much education arrives through commercial channels, independent appraisal should be a routine part of clinical practice. At the end of it all, patients are relying on our judgement when they agree to treatment.
Scan for references:
JORDAN FAULKNER
Dr Jordan Faulkner is a full-time cosmetic physician and founder of Allo Aesthetics. He is the founder and lead mentor of Unite Aesthetics Initiative and is a clinical educator at Interface Aesthetics. Dr Faulkner is a brand ambassador at Revanesse and faculty member at DermaFocus. He is the co-owner of Myokine Ltd. He won Rising Star of the Year at the Aesthetics Awards ‘25.